• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Horizons in Cancer Research: Volume 52

Horizons in Cancer Research: Volume 52

9781628080469
900,84 zł
810,75 zł Zniżka 90,09 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 810,75 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This book presents original research results on the leading edge of cancer. Topics discussed include coping mechanisms in patients with head and neck cancer; hepatocellular carcinoma; chronic lymphocytic leukaemia; the pathobiology of B-lymphoproliferative disorders from MBL to CLL to SLL; molecular and cellular characterisation of chronic lymphocytic leukemia; pain as a consequence in patients with early stage breast cancer treated with intracavity brachytherapy accelerated partial breast irradiation (IBAPBI); the future of anti-tumour immunotherapy; coping with childhood cancer; and the current clinical utility of Everolimus in the treatment of renal cell carcinoma.
Szczegóły produktu
74265
9781628080469
9781628080469

Opis

Rok wydania
2013
Numer wydania
1
Oprawa
twarda
Liczba stron
265
Wymiary (mm)
180.00 x 260.00
Waga (g)
618
  • Preface; Hepatocellular Carcinoma:: An Update; Coping Mechanisms in Patients with Head & Neck Cancer; Chronic Lymphocytic Leukemia:: Recent Progress & Unresolved Questions in Clinical Settings; Pathobiology of B-Lymphoproliferative Disorders:: from MBL to CLL & SLL; Molecular & Cellular Characterization of Chronic Lymphocytic Leukemia:: Prognostic Implications; Pain is a Consequence in Patients with Early Stage Breast Cancer Treated with Intracavitary Brachytherapy Accelerated Partial Breast Irradiation (IBAPBI); Looking into the Future of Immunotherapy or How to Find Cinderella; Coping with Childhood Cancer:: Interaction & Development of Self-Esteem & Defense Mechanisms; Everolimus for Renal Cell Carcinoma:: Clinical Utility & Adverse Reactions; Index.
Komentarze (0)